Search Results - "Yutaka HATTORI"

Refine Results
  1. 1

    A thermoresponsive cationic block copolymer brush-grafted silica bead interface for temperature-modulated separation of adipose-derived stem cells by Nagase, Kenichi, Okada, Akari, Matsuda, Junnosuke, Ichikawa, Daiju, Hattori, Yutaka, Kanazawa, Hideko

    Published in Colloids and surfaces, B, Biointerfaces (01-12-2022)
    “…Adipose-derived mesenchymal stem cells (ADSCs) have beneficial effects in cell transplantation therapy; these cells are collected from adipose tissue using…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Antibody drug separation using thermoresponsive anionic polymer brush modified beads with optimised electrostatic and hydrophobic interactions by Nagase, Kenichi, Ishii, Saki, Ikeda, Koji, Yamada, Sota, Ichikawa, Daiju, Akimoto, Aya Mizutani, Hattori, Yutaka, Kanazawa, Hideko

    Published in Scientific reports (27-07-2020)
    “…Antibody drugs play an important role in biopharmaceuticals, because of the specificity for target biomolecules and reduction of side effects. Thus, separation…”
    Get full text
    Journal Article
  4. 4

    Temperature-modulated cell-separation column using temperature-responsive cationic copolymer hydrogel-modified silica beads by Nagase, Kenichi, Inanaga, Daimu, Ichikawa, Daiju, Mizutani Akimoto, Aya, Hattori, Yutaka, Kanazawa, Hideko

    Published in Colloids and surfaces, B, Biointerfaces (01-06-2019)
    “…[Display omitted] •A thermoresponsive-cationic beads packed column was developed.•Retention and elution of cells was modulated by changing temperature.•Cell…”
    Get full text
    Journal Article
  5. 5

    Dietary Supplementation with Sodium Butyrate Reduces High-sucrose Diet-induced Hepatic Accumulation of Triacylglycerols and Expression of Fatty Acid Synthesis Enzymes in Rats by Hattori, Yutaka, Tsutsui, Sayo, Yamada, Chihiro, Kobayashi, Yota, Nakagawa, Tomoyuki, Shimada, Masaya

    Published in Journal of Oleo Science (01-01-2022)
    “…We investigated the effects of dietary supplementation with sodium butyrate (NaB) on the lipid levels, gene expression, and proteins related to lipid…”
    Get full text
    Journal Article
  6. 6

    Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells by Matsushita, Maiko, Kashiwazaki, Sho, Kamiko, Satoshi, Kobori, Michio, Osada, Makoto, Kunieda, Hisako, Hirao, Maki, Ichikawa, Daiju, Hattori, Yutaka

    Published in Pharmaceuticals (Basel, Switzerland) (27-09-2023)
    “…Several anti-cancer drugs are known to have immunomodulatory effects, including immunogenic cell death (ICD) of cancer cells. ICD is a form of apoptosis which…”
    Get full text
    Journal Article
  7. 7

    SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma by Yamamoto, Tomofumi, Nakayama, Jun, Yamamoto, Yusuke, Kuroda, Masahiko, Hattori, Yutaka, Ochiya, Takahiro

    Published in Blood advances (26-04-2022)
    “…Multiple myeloma (MM) is a hematopoietic malignancy whose prognosis has improved with the development of new agents such as lenalidomide over the last decade…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy by Matsushita, Maiko, Saito, Saku, Yokoe, Shinya, Ichikawa, Daiju, Hattori, Yutaka

    Published in Vaccines (Basel) (02-10-2020)
    “…Despite the availability of therapeutic treatments, multiple myeloma is an incurable haematological disorder. In this study, we aimed to clarify the role of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Identification of Novel HLA-A24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies by Matsushita, Maiko, Otsuka, Yohei, Tsutsumida, Naoya, Tanaka, Chiaki, Uchiumi, Akane, Ozawa, Koji, Suzuki, Takuma, Ichikawa, Daiju, Aburatani, Hiroyuki, Okamoto, Shinichiro, Kawakami, Yutaka, Hattori, Yutaka

    Published in PloS one (19-01-2016)
    “…The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Dietary Supplementation with Sodium Butyrate Reduces High-sucrose Diet-induced Hepatic Accumulation of Triacylglycerols and Expression of Fatty Acid Synthesis Enzymes in Rats by Yutaka Hattori, Sayo Tsutsui, Chihiro Yamada, Yota Kobayashi, Tomoyuki Nakagawa, Masaya Shimada

    Published in Journal of Oleo Science (01-08-2022)
    “…[Abstract] : We investigated the effects of dietary supplementation with sodium butyrate (NaB) on the lipid levels, gene expression, and proteins related to…”
    Get full text
    Journal Article
  16. 16

    A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts by Matsushita, Maiko, Ozaki, Yoshie, Hasegawa, Yuka, Terada, Fukiko, Tabata, Noriko, Shiheido, Hirokazu, Yanagawa, Hiroshi, Oikawa, Tsukasa, Matsuo, Koichi, Du, Wenlin, Yamada, Taketo, Hozumi, Masashi, Ichikawa, Daiju, Hattori, Yutaka

    Published in PloS one (24-01-2015)
    “…Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion…”
    Get full text
    Journal Article
  17. 17

    A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma by Shiheido, Hirokazu, Terada, Fukiko, Tabata, Noriko, Hayakawa, Ichigo, Matsumura, Nobutaka, Takashima, Hideaki, Ogawa, Yoko, Du, Wenlin, Yamada, Taketo, Shoji, Mitsuru, Sugai, Takeshi, Doi, Nobuhide, Iijima, Shiro, Hattori, Yutaka, Yanagawa, Hiroshi

    Published in PloS one (25-06-2012)
    “…Despite the introduction of newly developed drugs such as lenalidomide and bortezomib, patients with multiple myeloma are still difficult to treat and have a…”
    Get full text
    Journal Article
  18. 18

    An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II by Shiheido, Hirokazu, Naito, Yuhei, Kimura, Hironobu, Genma, Hiroaki, Takashima, Hideaki, Tokunaga, Mayuko, Ono, Takao, Hirano, Tatsuya, Du, Wenlin, Yamada, Taketo, Doi, Nobuhide, Iijima, Shiro, Hattori, Yutaka, Yanagawa, Hiroshi

    Published in PloS one (13-09-2012)
    “…We screened 46 novel anilinoquinazoline derivatives for activity to inhibit proliferation of a panel of human cancer cell lines. Among them, Q15 showed potent…”
    Get full text
    Journal Article
  19. 19

    Single‐institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile by Hattori, Yutaka, Okamoto, Shin‐ichiro, Shimada, Naoki, Kakimoto, Tsunayuki, Morita, Kunihiko, Tanigawara, Yusuke, Ikeda, Yasuo

    Published in Cancer science (01-06-2008)
    “…We previously reported a pilot study of thalidomide monotherapy for Japanese patients with refractory or relapsed multiple myeloma. In the present work, we…”
    Get full text
    Journal Article
  20. 20

    NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor by Du, Wenlin, Hattori, Yutaka, Yamada, Taketo, Matsumoto, Kunio, Nakamura, Toshikazu, Sagawa, Morihiko, Otsuki, Takemi, Niikura, Takako, Nukiwa, Toshihiro, Ikeda, Yasuo

    Published in Blood (01-04-2007)
    “…Hepatocyte growth factor (HGF) promotes cell growth and motility and also increases neovascularization. Multiple myeloma (MM) cells produce HGF, and the plasma…”
    Get full text
    Journal Article